Abstract: Adverse drug-drug interactions (DDIs) pose potential risks in polypharmacy due to unknown physicochemical incompatibilities between co-administered drugs. Recent studies have utilized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback